vs

Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $76.2M, roughly 1.0× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 3.4%, a 4.0% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 7.6%).

InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

IVT vs VMD — Head-to-Head

Bigger by revenue
IVT
IVT
1.0× larger
IVT
$77.4M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+16.9% gap
VMD
25.5%
8.6%
IVT
Higher net margin
VMD
VMD
4.0% more per $
VMD
7.4%
3.4%
IVT
More free cash flow
IVT
IVT
$101.2M more FCF
IVT
$110.9M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
7.6%
IVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVT
IVT
VMD
VMD
Revenue
$77.4M
$76.2M
Net Profit
$2.7M
$5.6M
Gross Margin
57.9%
Operating Margin
-11.0%
11.0%
Net Margin
3.4%
7.4%
Revenue YoY
8.6%
25.5%
Net Profit YoY
-72.8%
30.7%
EPS (diluted)
$0.02
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVT
IVT
VMD
VMD
Q4 25
$77.4M
$76.2M
Q3 25
$74.5M
$71.9M
Q2 25
$73.6M
$63.1M
Q1 25
$73.8M
$59.1M
Q4 24
$71.2M
$60.7M
Q3 24
$68.5M
$58.0M
Q2 24
$67.4M
$55.0M
Q1 24
$66.8M
$50.6M
Net Profit
IVT
IVT
VMD
VMD
Q4 25
$2.7M
$5.6M
Q3 25
$6.0M
$3.5M
Q2 25
$95.9M
$3.2M
Q1 25
$6.8M
$2.6M
Q4 24
$9.8M
$4.3M
Q3 24
$-539.0K
$3.9M
Q2 24
$1.5M
$1.5M
Q1 24
$2.9M
$1.6M
Gross Margin
IVT
IVT
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
IVT
IVT
VMD
VMD
Q4 25
-11.0%
11.0%
Q3 25
-9.8%
7.8%
Q2 25
8.1%
Q1 25
-10.5%
6.5%
Q4 24
-3.6%
10.6%
Q3 24
-18.7%
9.7%
Q2 24
-13.6%
6.6%
Q1 24
-13.1%
4.4%
Net Margin
IVT
IVT
VMD
VMD
Q4 25
3.4%
7.4%
Q3 25
8.1%
4.9%
Q2 25
130.4%
5.0%
Q1 25
9.2%
4.4%
Q4 24
13.8%
7.1%
Q3 24
-0.8%
6.7%
Q2 24
2.2%
2.7%
Q1 24
4.3%
3.2%
EPS (diluted)
IVT
IVT
VMD
VMD
Q4 25
$0.02
$0.14
Q3 25
$0.08
$0.09
Q2 25
$1.23
$0.08
Q1 25
$0.09
$0.06
Q4 24
$0.14
$0.10
Q3 24
$-0.01
$0.10
Q2 24
$0.02
$0.04
Q1 24
$0.04
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVT
IVT
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
$825.9M
Stockholders' EquityBook value
$1.8B
$141.5M
Total Assets
$2.8B
$199.2M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVT
IVT
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Total Debt
IVT
IVT
VMD
VMD
Q4 25
$825.9M
Q3 25
$764.6M
Q2 25
$746.3M
Q1 25
$740.7M
Q4 24
$740.4M
Q3 24
$740.1M
Q2 24
$812.2M
Q1 24
$827.5M
Stockholders' Equity
IVT
IVT
VMD
VMD
Q4 25
$1.8B
$141.5M
Q3 25
$1.8B
$133.6M
Q2 25
$1.8B
$139.7M
Q1 25
$1.7B
$134.8M
Q4 24
$1.8B
$131.4M
Q3 24
$1.8B
$125.0M
Q2 24
$1.5B
$119.4M
Q1 24
$1.5B
$116.3M
Total Assets
IVT
IVT
VMD
VMD
Q4 25
$2.8B
$199.2M
Q3 25
$2.7B
$202.4M
Q2 25
$2.7B
$184.6M
Q1 25
$2.6B
$178.1M
Q4 24
$2.6B
$177.1M
Q3 24
$2.6B
$169.5M
Q2 24
$2.5B
$163.9M
Q1 24
$2.5B
$154.9M
Debt / Equity
IVT
IVT
VMD
VMD
Q4 25
0.46×
Q3 25
0.42×
Q2 25
0.41×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.53×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVT
IVT
VMD
VMD
Operating Cash FlowLast quarter
$155.4M
$18.4M
Free Cash FlowOCF − Capex
$110.9M
$9.7M
FCF MarginFCF / Revenue
143.3%
12.7%
Capex IntensityCapex / Revenue
57.5%
11.5%
Cash ConversionOCF / Net Profit
58.41×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$193.1M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVT
IVT
VMD
VMD
Q4 25
$155.4M
$18.4M
Q3 25
$43.8M
$18.4M
Q2 25
$48.7M
$12.3M
Q1 25
$20.2M
$2.9M
Q4 24
$136.9M
$15.0M
Q3 24
$38.4M
$12.7M
Q2 24
$46.7M
$10.2M
Q1 24
$14.8M
$1.2M
Free Cash Flow
IVT
IVT
VMD
VMD
Q4 25
$110.9M
$9.7M
Q3 25
$31.4M
$10.7M
Q2 25
$38.0M
$4.1M
Q1 25
$12.8M
$-12.6M
Q4 24
$100.8M
$3.2M
Q3 24
$29.3M
$1.7M
Q2 24
$37.2M
$1.2M
Q1 24
$7.7M
$-4.8M
FCF Margin
IVT
IVT
VMD
VMD
Q4 25
143.3%
12.7%
Q3 25
42.2%
14.9%
Q2 25
51.6%
6.5%
Q1 25
17.4%
-21.4%
Q4 24
141.5%
5.2%
Q3 24
42.8%
3.0%
Q2 24
55.2%
2.3%
Q1 24
11.5%
-9.5%
Capex Intensity
IVT
IVT
VMD
VMD
Q4 25
57.5%
11.5%
Q3 25
16.7%
10.6%
Q2 25
14.6%
12.9%
Q1 25
10.0%
26.2%
Q4 24
50.7%
19.5%
Q3 24
13.3%
19.0%
Q2 24
14.0%
16.3%
Q1 24
10.6%
11.9%
Cash Conversion
IVT
IVT
VMD
VMD
Q4 25
58.41×
3.27×
Q3 25
7.27×
5.23×
Q2 25
0.51×
3.88×
Q1 25
2.97×
1.09×
Q4 24
13.97×
3.47×
Q3 24
3.29×
Q2 24
31.15×
6.94×
Q1 24
5.10×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons